The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population

Eur Heart J. 2003 Jun;24(12):1143-52. doi: 10.1016/s0195-668x(03)00199-4.

Abstract

Aims: To assess the prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in the chronically paced population.

Methods and results: Three hundred and seven patients were identified from attendance at routine pacemaker follow-up clinic. Subjects underwent a medical history and examination, 6-minute walk test and echocardiography. 94 (31%) had a left ventricular ejection fraction (LVEF) <40%, of whom 83 had symptoms of heart failure (70% NYHA II, 26% NYHA III and 4% NYHA IV). Heart failure was more prevalent in patients with single chamber compared to dual chamber pacemakers, (DDD(R) 18% vs 35% VVI(R), p<0.008), and those with chronic atrial fibrillation (AF) compared to those with sinus rhythm (42% vs 21%, p=0.003). Decreasing 6-minute walk distance, history of ischaemic heart disease and years of pacing were independently associated with the presence of heart failure (combined R=0.572, p<0.001).

Conclusions: Heart failure due to left ventricular systolic dysfunction is common in the paced population. Only a minority of these had a pre-existing diagnosis and a smaller proportion were on 'optimal' therapy. Echocardiographic screening of this high-risk population is justified to improve rates of diagnosis and treatment of heart failure.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Atrial Fibrillation / therapy
  • Blood Flow Velocity
  • Cardiac Output, Low / diagnosis*
  • Cardiac Pacing, Artificial*
  • Cardiovascular Agents / therapeutic use
  • Diabetic Angiopathies / complications
  • Double-Blind Method
  • Dyspnea / etiology
  • Echocardiography
  • Exercise Tolerance
  • Fatigue / etiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Stroke Volume / physiology
  • Ventricular Dysfunction, Left / diagnosis*

Substances

  • Cardiovascular Agents